☰

Alexander R. Judkins - Publications

Affiliations: 
Neuropathology University of Pennsylvania, Philadelphia, PA, United States 
Website:
http://www.chop.edu/doctors/judkins-alexander-r.html
Tree Info Similar researchers PubMed Report error

103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Xue Y, Zhu X, Meehan B, Venneti S, Martinez D, Morin G, Itoua Maïga R, Chen H, Papadakis AI, Johnson RM, O'Sullivan MJ, Erdreich-Epstein A, Gotlieb WH, Park M, Judkins AR, et al. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors. The Journal of Pathology. PMID 32558936 DOI: 10.1002/Path.5493  0.347
2020 Pratt D, Quezado M, Abdullaev Z, Hawes D, Yang F, Garton HJL, Judkins AR, Mody R, Chinnaiyan A, Aldape K, Koschmann C, Venneti S. Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma. Acta Neuropathologica Communications. 8: 37. PMID 32197665 DOI: 10.1186/S40478-020-00905-W  0.343
2020 Hoffman LM, Richardson EA, Ho B, Margol A, Reddy A, Lafay-Cousin L, Chi S, Slavc I, Judkins A, Hasselblatt M, Bourdeaut F, Frühwald MC, Vibhakar R, Bouffet E, Huang A. Advancing biology based therapeutic approaches for atypical teratoid rhabdoid tumors. Neuro-Oncology. PMID 32129445 DOI: 10.1093/Neuonc/Noaa046  0.385
2020 Reddy AT, Strother DR, Judkins AR, Burger PC, Pollack IF, Krailo MD, Buxton AB, Williams-Hughes C, Fouladi M, Mahajan A, Merchant TE, Ho B, Mazewski CM, Lewis VA, Gajjar A, et al. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901776. PMID 32105509 DOI: 10.1200/Jco.19.01776  0.334
2020 Panwalkar P, Pratt D, Chung C, Dang D, Le P, Martinez D, Bayliss JM, Smith KS, Adam M, Potter S, Northcott P, Mascarenhas L, Shows J, Pawel B, Margol A, ... ... Judkins AR, et al. SWI/SNF complex heterogeneity relates with polyphenotypic differentiation, prognosis and immune response in rhabdoid tumors. Neuro-Oncology. PMID 31912158 DOI: 10.1093/Neuonc/Noaa004  0.342
2020 Li BK, Burger P, Judkins AR, Ho BLB, Kang G, Gossett J, Leary S, Pollack I, Gajjar A, Fouladi M, Kellie SJ, Mazewski C, Huang A. PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP Neuro-Oncology. 22: iii429-iii429. DOI: 10.1093/neuonc/noaa222.659  0.302
2019 Tamrazi B, Venneti S, Margol A, Hawes D, Cen SY, Nelson M, Judkins A, Biegel J, Blüml S. Pediatric Atypical Teratoid/Rhabdoid Tumors of the Brain: Identification of Metabolic Subgroups Using In Vivo H-MR Spectroscopy. Ajnr. American Journal of Neuroradiology. PMID 30948375 DOI: 10.3174/Ajnr.A6024  0.384
2019 Toll SA, Tran HN, Cotter J, Judkins AR, Tamrazi B, Biegel JA, Dhall G, Robison NJ, Waters K, Patel P, Cooper R, Margol AS. Sustained response of three pediatric BRAF mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy. Oncotarget. 10: 551-557. PMID 30728904 DOI: 10.18632/Oncotarget.26560  0.304
2019 Xue Y, Meehan B, Macdonald E, Venneti S, Wang XQD, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson RM, Cencic R, Patibandla J, ... ... Judkins AR, et al. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nature Communications. 10: 558. PMID 30718512 DOI: 10.1038/S41467-018-06958-9  0.306
2019 Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, Levins C, Kong T, Zhu X, Morin G, Skerritt L, Herpel E, Venneti S, Martinez D, Judkins AR, et al. SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer. Nature Communications. 10: 557. PMID 30718506 DOI: 10.1038/S41467-019-08380-1  0.667
2019 Vitte J, Gao F, Coppola G, Judkins AR, Giovannini M. TMOD-15. SPATIOTEMPORAL LOSS OF SMARCB1 IN EARLY NEURAL CREST LINEAGE LEADS TO DIFFERENT MOLECULAR SUBTYPES OF RHABDOID TUMORS Neuro-Oncology. 21: ii124-ii124. DOI: 10.1093/Neuonc/Noz036.252  0.335
2018 Hiemenz MC, Ostrow DG, Busse TM, Buckley J, Maglinte DT, Bootwalla M, Done J, Ji J, Raca G, Ryutov A, Xu X, Zhen CJ, Conroy JM, Hazard FK, Deignan JL, ... ... Judkins AR, et al. OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies. The Journal of Molecular Diagnostics : Jmd. PMID 30138724 DOI: 10.1016/J.Jmoldx.2018.06.009  0.374
2018 Kaneva K, Hiemenz M, Ji J, Robison N, Margol A, Dhall G, Cotter J, Hawes D, Judkins A, Biegel JA. TBIO-05. INTEGRATION OF GENOMIC DATA FROM THE ONCOKIDSSM NEXT GENERATION SEQUENCING PANEL AND CHROMOSOMAL MICROARRAY ANALYSIS FOR DIAGNOSIS AND PROGNOSIS OF PEDIATRIC CNS TUMORS Neuro-Oncology. 20: i181-i181. DOI: 10.1093/Neuonc/Noy059.694  0.318
2018 Ho B, Fonseca A, Al-Karmi S, Margol A, Yao F, Cheng S, Grant R, Handsford J, Gupta A, Vasiljevic A, Pawel B, Jabado N, Hawkins C, Lafay-Cousin L, Judkins A, et al. ATRT-40. IMPACT OF MOLECULAR SUBTYPES ON TREATMENT OUTCOMES IN RHABDOID TUMORS - A REPORT FROM THE RARE TUMOR CONSORTIUM Neuro-Oncology. 20: i36-i36. DOI: 10.1093/Neuonc/Noy059.037  0.356
2018 Venneti S, Panwalkar P, Chung C, Pratt D, Martinez D, Bayliss J, Paran C, Hawes D, Pawel B, Judkins A. ATRT-22. SWI/SNF COMPLEX HETEROGENEITY RELATES WITH POLYPHENOTYPIC DIFFERENTIATION AND THE IMMUNE MICRO ENVIRONMENT IN RHABDOID TUMORS Neuro-Oncology. 20: i32-i32. DOI: 10.1093/Neuonc/Noy059.020  0.306
2017 Vitte J, Gao F, Coppola G, Judkins AR, Giovannini M. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development. Nature Communications. 8: 300. PMID 28824165 DOI: 10.1038/S41467-017-00346-5  0.392
2017 Panwalkar P, Clark J, Ramaswamy V, Hawes D, Yang F, Dunham C, Yip S, Hukin J, Sun Y, Schipper MJ, Chavez L, Margol A, Pekmezci M, Chung C, Banda A, ... ... Judkins AR, et al. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathologica. PMID 28733933 DOI: 10.1007/S00401-017-1752-4  0.388
2017 Venneti S, Bayliss J, Mukherjee P, Lu C, Jain S, Chung C, Martinez D, Sabari B, Margol A, Panwalkar P, Paroloia A, Pekmezci M, Eachin RM, Cieslik M, Tamrazi B, ... ... Judkins AR, et al. Abstract 3863: A subset of poorly prognostic pediatric posterior fossa ependymomas exhibit lowered H3K27me3 and DNA hypomethylation and show epigenetic similarities with H3K27M mutant diffuse intrinsic pontine gliomas Cancer Research. 77: 3863-3863. DOI: 10.1158/1538-7445.Am2017-3863  0.387
2017 Biegel J, Triche T, Ostrow DG, Buckley J, Busse T, Gai X, Judkins A, Maglinte D, Raca G, Hiemenz M. Detection of Gene Fusions in Pediatric Hematologic Malignancies and Solid Tumors With the OncoKids Next Generation Sequencing Based Assay Cancer Genetics and Cytogenetics. 214: 41. DOI: 10.1016/J.Cancergen.2017.04.030  0.339
2016 Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, ... ... Judkins AR, et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30: 891-908. PMID 27960086 DOI: 10.1016/J.Ccell.2016.11.003  0.335
2016 Bayliss J, Mukherjee P, Lu C, Jain SU, Chung C, Martinez D, Sabari B, Margol AS, Panwalkar P, Parolia A, Pekmezci M, McEachin RC, Cieslik M, Tamrazi B, Garcia BA, ... ... Judkins AR, et al. Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Science Translational Medicine. 8: 366ra161. PMID 27881822 DOI: 10.1126/Scitranslmed.Aah6904  0.385
2016 Li WL, Buckley J, Sanchez-Lara PA, Maglinte DT, Viduetsky L, Tatarinova TV, Aparicio JG, Kim J, Au M, Ostrow D, Lee T, O'Gorman M, Judkins A, Cobrinik D, Triche TJ. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families. The Journal of Molecular Diagnostics : Jmd. PMID 27155049 DOI: 10.1016/J.Jmoldx.2016.02.006  0.317
2016 Torchia J, Feng S, Ho KC, Letourneau L, Picard D, Chan TS, Vasiljevic A, Quang DAK, Golbourn B, Barsyte-Lovejoy D, Zeller C, Sin-Chan P, Agamez NR, Lu M, Lafay-Cousin L, ... ... Judkins AR, et al. Abstract LB-179: Integrated (epi)genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-179  0.367
2016 Panwalkar P, Martinez D, Bayliss J, Khatri S, Judkins A, Venneti S. GENT-45. HETEROGENEITY OF SWI-SNF COMPONENTS IN MALIGNANT RHABDOID TUMORS Neuro-Oncology. 18: vi84-vi84. DOI: 10.1093/Neuonc/Now212.351  0.355
2016 Abongwa C, Margol A, Ahmed A, Robison N, Tamrazi B, Judkins A, Dhall G. AT-23ENCOURAGING SURVIVAL OF PEDIATRIC CENTRAL NERVOUS SYSTEM (CNS) ATYPICAL TERATOID AND RHABDOID TUMOR (AT/RT) TREATED AS PER CHILDREN'S ONCOLOGY GROUP ACNS0333 STUDY: A SINGLE-INSTITUTION EXPERIENCE Neuro-Oncology. 18: iii6.3-iii6. DOI: 10.1093/Neuonc/Now065.22  0.336
2016 Torchia J, Feng S, Ho KC, Letourneau L, Picard D, Chan TS, Vasiljevic A, Quang DAK, Golbourn B, Barsyte-Lovejoy D, Zeller C, Sin-Chan P, Agamez NR, Lu M, Lafay-Cousin L, ... ... Judkins AR, et al. AT-21INTEGRATED (EPI)GENOMIC ANALYSES IDENTIFY SUB-GROUP SPECIFIC THERAPEUTIC TARGETS IN CNS RHABDOID TUMORS Neuro-Oncology. 18: iii6.1-iii6. DOI: 10.1093/Neuonc/Now065.20  0.311
2016 Reddy A, Strother D, Judkins A, Krailo M, Gao Y, Douglas J, Mahajan A, Lewis V, Mazewski C, Laningham F, Pollack I, Gajjar A, Biegel J. AT-09TREATMENT OF ATYPICAL TERATOID RHABDOID TUMORS (ATRT) OF THE CENTRAL NERVOUS SYSTEM WITH SURGERY, INTENSIVE CHEMOTHERAPY, AND 3-D CONFORMAL RADIATION (ACNS0333). A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP Neuro-Oncology. 18: iii2.4-iii2. DOI: 10.1093/Neuonc/Now065.08  0.301
2016 Tamrazi B, Nelson M, Judkins A, Margol A, Biegel J, Bluml S. AT-02MR SPECTROSCOPY AND METABOLIC SUBTYPES OF ATYPICAL TERATOID RHABDOID TUMORS IN CHILDREN Neuro-Oncology. 18: iii1.1-iii1. DOI: 10.1093/Neuonc/Now065.01  0.316
2015 Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, et al. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy. Neuro-Oncology. PMID 26254476 DOI: 10.1093/Neuonc/Nov097  0.309
2015 Margol AS, Robison NJ, Gnanachandran J, Hung LT, Kennedy RJ, Vali M, Dhall G, Finlay JL, Erdreich-Epstein A, Krieger MD, Drissi R, Fouladi M, Gilles FH, Judkins AR, Sposto R, et al. Tumor-associated macrophages in SHH subgroup of medulloblastomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1457-65. PMID 25344580 DOI: 10.1158/1078-0432.Ccr-14-1144  0.375
2015 Venneti S, Santi M, Felicella MM, Yarilin D, Phillips J, Sullivan L, Martinez D, Perry A, Lewis P, Thompson C, Judkins A. HG-07 * DETECTION OF K27M MUTANT PEDIATRIC GLIOBLASTOMAS BY IMMUNOHISTOCHEMISTRY Neuro-Oncology. 17: iii12-iii12. DOI: 10.1093/Neuonc/Nov061.44  0.401
2015 Vitte J, Chareyre F, Stemmer-Rachamimov A, Judkins A, Giovannini M. PM-02 * CONDITIONAL INACTIVATION OF SMARCB1 IN P0 PERMISSIVE MOUSE CELLS GENERATES RHABDOID TUMORS IN THE PERIPHERAL NERVOUS SYSTEM AND IN THE BRAIN Neuro-Oncology. 17: iii31-iii31. DOI: 10.1093/Neuonc/Nov061.125  0.407
2014 Margol AS, Judkins AR. Pathology and diagnosis of SMARCB1-deficient tumors. Cancer Genetics. 207: 358-64. PMID 25246033 DOI: 10.1016/J.Cancergen.2014.07.004  0.411
2014 Zhang J, Fan J, Venneti S, Cross JR, Takagi T, Bhinder B, Djaballah H, Kanai M, Cheng EH, Judkins AR, Pawel B, Baggs J, Cherry S, Rabinowitz JD, Thompson CB. Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Molecular Cell. 56: 205-18. PMID 25242145 DOI: 10.1016/J.Molcel.2014.08.018  0.302
2014 Venneti S, Santi M, Felicella MM, Yarilin D, Phillips JJ, Sullivan LM, Martinez D, Perry A, Lewis PW, Thompson CB, Judkins AR. A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathologica. 128: 743-53. PMID 25200322 DOI: 10.1007/S00401-014-1338-3  0.385
2014 Erdreich-Epstein A, Robison N, Ren X, Zhou H, Xu J, Davidson TB, Schur M, Gilles FH, Ji L, Malvar J, Shackleford GM, Margol AS, Krieger MD, Judkins AR, Jones DT, et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 827-36. PMID 24300787 DOI: 10.1158/1078-0432.Ccr-13-2053  0.373
2014 Margol A, Gnanachandran J, Robison N, Hung L, Kennedy R, Vali M, Dhall G, Finlay J, Epstein A, Krieger M, Dorris K, Fouladi M, Gilles F, Judkins A, Sposto R, et al. Abstract B18: Presence of tumor-associated macrophages in SHH medulloblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B18  0.398
2014 Judkins AR, Venneti S, Santi M, Felicella MM, Sullivan LM, Dolgalev I, Martinez D, Perry A, Lewis PW, Allis DC, Thompson CB. HISTOPATHOLOGIC EVALUATION OF H3K27ME3 IS A PROGNOSTIC BIOMARKER FOR PEDIATRIC GLIOBLASTOMAS Neuro-Oncology. 16: iii29-iii30. DOI: 10.1093/Neuonc/Nou208.26  0.396
2014 Vitte J, Chareyre F, Stemmer-Rachamimov A, Judkins A, Giovannini M. Conditional Inactivation of SMARCB1 in P0 Permissive Mouse Cells Generates Rhabdoid Tumors in the Peripheral Nervous System Cancer Genetics. 207: 451. DOI: 10.1016/J.Cancergen.2014.09.023  0.342
2013 Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1425-32. PMID 23765250 DOI: 10.1038/Modpathol.2013.90  0.725
2013 Venneti S, Felicella MM, Coyne T, Phillips JJ, Gorovets D, Huse JT, Kofler J, Lu C, Tihan T, Sullivan LM, Santi M, Judkins AR, Perry A, Thompson CB. Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas. Journal of Neuropathology and Experimental Neurology. 72: 298-306. PMID 23481705 DOI: 10.1097/Nen.0B013E3182898113  0.564
2013 Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathology (Zurich, Switzerland). 23: 565-73. PMID 23438035 DOI: 10.1111/Bpa.12043  0.722
2013 Venneti S, Garimella MT, Sullivan LM, Martinez D, Huse JT, Heguy A, Santi M, Thompson CB, Judkins AR. Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathology (Zurich, Switzerland). 23: 558-64. PMID 23414300 DOI: 10.1111/Bpa.12042  0.579
2013 Sullivan LM, Folpe AL, Pawel BR, Judkins AR, Biegel JA. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 385-92. PMID 23060122 DOI: 10.1038/Modpathol.2012.175  0.397
2012 Cruz-Roa A, González F, Galaro J, Judkins AR, Ellison D, Baccon J, Madabhushi A, Romero E. A visual latent semantic approach for automatic analysis and interpretation of anaplastic medulloblastoma virtual slides. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 15: 157-64. PMID 23285547  0.667
2012 Heuer GG, Orlova KA, Pollock AN, Guzman MA, Judkins AR, Storm PB. Intracranial sarcoma metastasizing along distal shunt tubing. Pediatric Neurosurgery. 48: 62-3. PMID 22922301 DOI: 10.1159/000335445  0.501
2012 Hertwig F, Meyer K, Braun S, Ek S, Spang R, Pfenninger CV, Artner I, Prost G, Chen X, Biegel JA, Judkins AR, Englund E, Nuber UA. Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells. Cancer Research. 72: 3381-92. PMID 22719073 DOI: 10.1158/0008-5472.Can-11-3525  0.385
2012 Stephen JH, Sievert AJ, Madsen PJ, Judkins AR, Resnick AC, Storm PB, Rushing EJ, Santi M. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases. Journal of Neurosurgery. Pediatrics. 9: 646-53. PMID 22656257 DOI: 10.3171/2012.2.Peds11285  0.399
2012 Lang SS, Beslow LA, Gabel B, Judkins AR, Fisher MJ, Sutton LN, Storm PB, Heuer GG. Surgical treatment of brain tumors in infants younger than six months of age and review of the literature. World Neurosurgery. 78: 137-44. PMID 22120270 DOI: 10.1016/J.Wneu.2011.09.012  0.369
2012 Carter JM, O'Hara C, Dundas G, Gilchrist D, Collins MS, Eaton K, Judkins AR, Biegel JA, Folpe AL. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. The American Journal of Surgical Pathology. 36: 154-60. PMID 22082606 DOI: 10.1097/Pas.0B013E3182380802  0.38
2012 Venneti S, Boateng LA, Friedman JR, Baldwin DA, Tobias JW, Judkins AR, Mourelatos Z, Lal P. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS. Brain Pathology (Zurich, Switzerland). 22: 522-9. PMID 22082152 DOI: 10.1111/J.1750-3639.2011.00551.X  0.496
2012 Sullivan LM, Yankovich T, Le P, Martinez D, Santi M, Biegel JA, Pawel BR, Judkins AR. Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors. The American Journal of Surgical Pathology. 36: 73-80. PMID 21989342 DOI: 10.1097/Pas.0B013E31822Cfa7E  0.396
2011 Galaro J, Judkins AR, Ellison D, Baccon J, Madabhushi A. An integrated texton and bag of words classifier for identifying anaplastic medulloblastomas. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2011: 3443-6. PMID 22255080 DOI: 10.1109/IEMBS.2011.6090931  0.669
2011 Venneti S, Le P, Martinez D, Xie SX, Sullivan LM, Rorke-Adams LB, Pawel B, Judkins AR. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins. The American Journal of Surgical Pathology. 35: 1463-72. PMID 21921784 DOI: 10.1097/Pas.0B013E318224D2Cd  0.685
2011 Heuer GG, Fenning RS, Brown M, Kilbaugh T, Guzman MA, Judkins AR, Rorke-Adams L, Sutton LN, Storm PB. Pulmonary edema and cardiac dysfunction after resection of a fourth ventricle tumor in a toddler: case report. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 27: 2005-9. PMID 21915724 DOI: 10.1007/S00381-011-1573-Z  0.715
2011 Venneti S, Le P, Martinez D, Eaton KW, Shyam N, Jordan-Sciutto KL, Pawel B, Biegel JA, Judkins AR. p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. Journal of Neuropathology and Experimental Neurology. 70: 596-609. PMID 21666498 DOI: 10.1097/Nen.0B013E31822146Ca  0.368
2011 Judkins AR, Martinez D, Ferreira P, Dobyns WB, Golden JA. Polymicrogyria includes fusion of the molecular layer and decreased neuronal populations but normal cortical laminar organization. Journal of Neuropathology and Experimental Neurology. 70: 438-43. PMID 21572338 DOI: 10.1097/Nen.0B013E31821Ccf1C  0.585
2011 Hasselblatt M, Gesk S, Oyen F, Rossi S, Viscardi E, Giangaspero F, Giannini C, Judkins AR, Frühwald MC, Obser T, Schneppenheim R, Siebert R, Paulus W. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. The American Journal of Surgical Pathology. 35: 933-5. PMID 21566516 DOI: 10.1097/Pas.0B013E3182196A39  0.4
2011 Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, ... ... Judkins AR, et al. The genetic landscape of the childhood cancer medulloblastoma. Science (New York, N.Y.). 331: 435-9. PMID 21163964 DOI: 10.1126/Science.1198056  0.37
2011 Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatric Blood & Cancer. 56: 7-15. PMID 21108436 DOI: 10.1002/Pbc.22831  0.389
2011 Lai Y, Viswanath S, Baccon J, Ellison D, Judkins AR, Madabhushi A. A texture-based classifier to discriminate anaplastic from non-anaplastic medulloblastoma 2011 Ieee 37th Annual Northeast Bioengineering Conference, Nebec 2011. DOI: 10.1109/NEBC.2011.5778641  0.656
2011 Tchikindas L, Sparks R, Baccon J, Ellison D, Judkins AR, Madabhushi A. Segmentation of nodular medulloblastoma using random walker and hierarchical normalized cuts 2011 Ieee 37th Annual Northeast Bioengineering Conference, Nebec 2011. DOI: 10.1109/NEBC.2011.5778640  0.642
2010 Evans SM, Jenkins KW, Chen HI, Jenkins WT, Judy KD, Hwang WT, Lustig RA, Judkins AR, Grady MS, Hahn SM, Koch CJ. The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study. Translational Oncology. 3: 160-9. PMID 20563257 DOI: 10.1593/Tlo.09265  0.318
2010 Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Santi M, Judkins AR, Rushing EJ. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases. Annals of Diagnostic Pathology. 14: 8-14. PMID 20123451 DOI: 10.1016/J.Anndiagpath.2009.09.003  0.372
2010 Heuer GG, Kiefer H, Judkins AR, Belasco J, Biegel JA, Jackson EM, Cohen M, O'Malley BW, Storm PB. Surgical treatment of a clival-C2 atypical teratoid/rhabdoid tumor. Journal of Neurosurgery. Pediatrics. 5: 75-9. PMID 20043739 DOI: 10.3171/2009.8.Peds08421  0.362
2010 Judkins AR, Ellison DW. Ependymoblastoma: dear, damned, distracting diagnosis, farewell!*. Brain Pathology (Zurich, Switzerland). 20: 133-9. PMID 19120373 DOI: 10.1111/J.1750-3639.2008.00253.X  0.4
2009 Guzman M, Judkins AR. Digital pathology: a tool for 21st century neuropathology. Brain Pathology (Zurich, Switzerland). 19: 305-16. PMID 19290997 DOI: 10.1111/J.1750-3639.2009.00264.X  0.513
2009 Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1923-30. PMID 19276269 DOI: 10.1158/1078-0432.Ccr-08-2091  0.358
2009 Samaras V, Stamatelli A, Samaras E, Stergiou I, Konstantopoulou P, Varsos V, Judkins AR, Biegel JA, Barbatis C. Atypical teratoid/rhabdoid tumor of the central nervous system in an 18-year-old patient. Clinical Neuropathology. 28: 1-10. PMID 19216214 DOI: 10.5414/Npp28001  0.419
2009 Sievert AJ, Jackson EM, Gai X, Hakonarson H, Judkins AR, Resnick AC, Sutton LN, Storm PB, Shaikh TH, Biegel JA. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathology (Zurich, Switzerland). 19: 449-58. PMID 19016743 DOI: 10.1111/J.1750-3639.2008.00225.X  0.338
2009 Kreiger PA, Judkins AR, Russo PA, Biegel JA, Lestini BJ, Assanasen C, Pawel BR. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 22: 142-50. PMID 18997735 DOI: 10.1038/Modpathol.2008.185  0.431
2009 Schessl J, Zou Y, McGrath M, Cowling B, Maiti B, Chin S, Sewry C, Battini R, Hu Y, Cottle D, Rosenblatt M, Spruce L, Ganguly A, Kirschner J, Judkins A, et al. Proteomic identification of the LIM domain protein FHL1 as the gene-product mutated in reducing body myopathy Klinische Neurophysiologie. 40. DOI: 10.1055/S-0029-1216187  0.57
2008 Evans SM, Jenkins KW, Jenkins WT, Dilling T, Judy KD, Schrlau A, Judkins A, Hahn SM, Koch CJ. Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors Radiation Research. 170: 677-690. PMID 19138031 DOI: 10.1667/Rr1207.1  0.336
2008 Schessl J, Zou Y, McGrath MJ, Cowling BS, Maiti B, Chin SS, Sewry C, Battini R, Hu Y, Cottle DL, Rosenblatt M, Spruce L, Ganguly A, Kirschner J, Judkins AR, et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. The Journal of Clinical Investigation. 118: 904-12. PMID 18274675 DOI: 10.1172/Jci34450  0.587
2008 Winter C, Pawel B, Seiser E, Zhao H, Raabe E, Wang Q, Judkins AR, Attiyeh E, Maris JM. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status. Pediatric Blood & Cancer. 51: 10-6. PMID 18213713 DOI: 10.1002/Pbc.21475  0.352
2008 Schessl J, Zou Y, McGrath MJ, Cowling BS, Maiti B, Chin SS, Sewry C, Battini R, Hu Y, Cottle DL, Rosenblatt M, Spruce L, Ganguly A, Kirschner J, Judkins AR, et al. G.O.2 Proteomic identification of the LIM domain protein FHL1 as the gene-product mutated in reducing body myopathy Neuromuscular Disorders. 18: 725-726. DOI: 10.1016/J.Nmd.2008.06.012  0.565
2007 Judkins AR. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Advances in Anatomic Pathology. 14: 335-9. PMID 17717433 DOI: 10.1097/Pap.0B013E3180Ca8B08  0.399
2007 Chacko G, Chacko AG, Dunham CP, Judkins AR, Biegel JA, Perry A. Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma. Journal of Neuro-Oncology. 84: 217-22. PMID 17431546 DOI: 10.1007/S11060-007-9361-Z  0.392
2007 Judkins AR, Dobyns WB, Golden JA. Pathological subtypes of polymicrogyria and brain development Journal of Neuropathology and Experimental Neurology. 66: 436. DOI: 10.1097/01.Jnen.0000268878.60312.C9  0.574
2007 Judkins AR, Dobyns WB, Golden JA. Pathological subtypes of polymicrogyria and brain development The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A75  0.574
2006 Armstrong GT, Phillips PC, Rorke-Adams LB, Judkins AR, Localio AR, Fisher MJ. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia. Cancer. 107: 1597-606. PMID 16955507 DOI: 10.1002/Cncr.22210  0.679
2006 Charboneau A, Chai J, Jordan J, Funkhouser W, Judkins A, Biegel J, Weissman B. P-Akt expression distinguishes two types of malignant rhabdoid tumors. Journal of Cellular Physiology. 209: 422-7. PMID 16897758 DOI: 10.1002/Jcp.20737  0.387
2006 Judkins AR, Porter BE, Cook N, Clancy RR, Duhaime AC, Golden JA. Dystrophic neuritic processes in epileptic cortex. Epilepsy Research. 70: 49-58. PMID 16631351 DOI: 10.1016/J.Eplepsyres.2006.03.006  0.586
2006 Rushing EJ, Sandberg GD, Judkins AR, Vezina G, Kadom N, Myseros JS, Packer RJ, Santi M. Germinoma: unusual imaging and pathological characteristics. Report of two cases. Journal of Neurosurgery. 104: 143-8. PMID 16506503 DOI: 10.3171/Ped.2006.104.2.12  0.323
2006 Allen JC, Judkins AR, Rosenblum MK, Biegel JA. Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case study. Neuro-Oncology. 8: 79-82. PMID 16443951 DOI: 10.1215/S1522851705000347  0.392
2006 Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, Pridjian G, Tan L, Judkins AR, Biegel JA. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatric Blood & Cancer. 47: 279-84. PMID 16261613 DOI: 10.1002/Pbc.20622  0.376
2006 Armstrong GT, Phillips PC, Rorke-Adams LB, Judkins A, Localio AR, Fisher MJ. Gliomatosis Cerebri: A pediatric case series and review of the literature Journal of Clinical Oncology. 24: 9056-9056. DOI: 10.1200/Jco.2006.24.18_Suppl.9056  0.684
2005 Simon SL, Moonis G, Judkins AR, Scobie J, Burnett MG, Riina HA, Judy KD. Intracranial capillary hemangioma: case report and review of the literature. Surgical Neurology. 64: 154-9. PMID 16051010 DOI: 10.1016/J.Surneu.2004.10.025  0.339
2005 Tu PH, Giannini C, Judkins AR, Schwalb JM, Burack R, O'Neill BP, Yachnis AT, Burger PC, Scheithauer BW, Perry A. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5718-27. PMID 16009945 DOI: 10.1200/Jco.2005.17.624  0.585
2005 Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. Journal of Neuropathology and Experimental Neurology. 64: 391-7. PMID 15892296 DOI: 10.1093/Jnen/64.5.391  0.633
2005 Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathology (Zurich, Switzerland). 15: 23-8. PMID 15779233 DOI: 10.1111/J.1750-3639.2005.Tb00096.X  0.397
2005 Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 18: 951-8. PMID 15761491 DOI: 10.1038/Modpathol.3800375  0.382
2004 Huang JH, Tsui I, Judkins AR, Simon E, Birknes JK, Sutton LN. Intramedullary cervical spine germinoma: case report. Neurosurgery. 55: 1432. PMID 15574227 DOI: 10.1227/01.Neu.0000143146.29632.38  0.333
2004 Hoot AC, Russo P, Judkins AR, Perlman EJ, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. The American Journal of Surgical Pathology. 28: 1485-91. PMID 15489652 DOI: 10.1097/01.Pas.0000141390.14548.34  0.374
2004 Telfeian AE, Judkins A, Younkin D, Pollock AN, Crino P. Subependymal giant cell astrocytoma with cranial and spinal metastases in a patient with tuberous sclerosis. Case report. Journal of Neurosurgery. 100: 498-500. PMID 15287462 DOI: 10.3171/Ped.2004.100.5.0498  0.328
2004 Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. The American Journal of Surgical Pathology. 28: 644-50. PMID 15105654 DOI: 10.1097/00000478-200405000-00013  0.418
2004 Evans SM, Judy KD, Dunphy I, Jenkins WT, Nelson PT, Collins R, Wileyto EP, Jenkins K, Hahn SM, Stevens CW, Judkins AR, Phillips P, Geoerger B, Koch CJ. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Research. 64: 1886-92. PMID 14996753 DOI: 10.1158/0008-5472.Can-03-2424  0.547
2004 Skovronsky D, Judkins AR, Kung M, Forman M, Martinez D, Hou C, Zhuang Z, Kung HF. P3-079 Characterization of neurodegenerative disease radioligands by tissue microarray analysis Neurobiology of Aging. 25: S375-S376. DOI: 10.1016/S0197-4580(04)81231-4  0.683
2003 Porter BE, Judkins AR, Clancy RR, Duhaime A, Dlugos DJ, Golden JA. Dysplasia: a common finding in intractable pediatric temporal lobe epilepsy. Neurology. 61: 365-8. PMID 12913199 DOI: 10.1212/01.Wnl.0000076487.28227.6E  0.568
2003 Myung RJ, Kirshbom PM, Petko M, Golden JA, Judkins AR, Ittenbach RF, Spray TL, Gaynor JW. Modified ultrafiltration may not improve neurologic outcome following deep hypothermic circulatory arrest. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 24: 243-8. PMID 12895615 DOI: 10.1016/S1010-7940(03)00298-7  0.571
2002 Judkins AR, Forman MS, Uryu K, Hinkle DA, Asbury AK, Lee VM, Trojanowski JQ. Co-occurrence of Parkinson's disease with progressive supranuclear palsy. Acta Neuropathologica. 103: 526-30. PMID 11935271 DOI: 10.1007/S00401-001-0483-7  0.647
1999 Judkins AR, Roberts SA, Livolsi VA. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors. Human Pathology. 30: 1373-6. PMID 10571520 DOI: 10.1016/S0046-8177(99)90071-0  0.311
1998 Judkins AR, Montone KT, LiVolsi VA, van de Rijn M. Sensitivity and specificity of antibodies on necrotic tumor tissue. American Journal of Clinical Pathology. 110: 641-6. PMID 9802350 DOI: 10.1093/Ajcp/110.5.641  0.309
Show low-probability matches.